Status:
ACTIVE_NOT_RECRUITING
The Importance of Insulin Action in the Brain for the Immune System During Physical Activity
Lead Sponsor:
University of Ulm
Conditions:
Insulin Sensitivity
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to clarify the interaction of central insulin action and physical activity with the immune system. Therefore, participants will undergo bicycle spiroergometer tests...
Detailed Description
This research project aims to investigate if the brain insulin action regulates the immune system via the autonomous nervous system during physical activity. Therefore, insulin action in the brain wi...
Eligibility Criteria
Inclusion
- BMI \< 24 kg/m2
- no known primary diseases
- hormonal contraception with a single-phase preparation
Exclusion
- Alcohol or drug abuse
- Smoking
- At screening: Hb \< 12 g/dl for women and Hb \< 14 g/dl for men
- Any (clinical) condition that would endanger participant's safety or question scientific success according to a physician's opinion.
Key Trial Info
Start Date :
December 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06552130
Start Date
December 15 2024
End Date
September 1 2026
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universityhospital Ulm
Ulm, Germany, 89081